Stay updated on Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.

Latest updates to the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Gorlin syndrome as a related term and included the Genetic and Rare Diseases Information Center as a new resources link.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedSite revision updated to version 3.5.0 and previous version 3.4.3 was removed.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page revision label changed from v3.4.2 to v3.4.3, indicating a system update. No substantive study information or eligibility details were altered.SummaryDifference0.1%

- Check64 days agoChange DetectedAn updated site revision tag is visible (Revision: v3.4.2), and the previous funding notice and earlier revision tag (v3.4.1) have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedAdded a government funding lapse notice and updated the site version from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check79 days agoChange DetectedGlossary is now shown on the page. Metadata updates include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision tag 'Revision: v3.4.0'.SummaryDifference0.2%

Stay in the know with updates to Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.